AstraZeneca sues FDA over generic Seroquel

LONDON (Reuters) – AstraZeneca said on Tuesday it was suing the Food and Administration after the U.S. regulator refused to delay the market entry later this month of generic versions of top-selling antipsychotic Seroquel. The drugmaker is seeking an injunction barring the FDA from granting final marketing approval of generic forms of the drug, whose chemical name is quetiapine, until December 2, 2012, or at least until a federal court has a chance to review the agency’s action. …